[$^{11}$C]glyburide PET imaging for quantitative determination of the importance of Organic Anion-Transporting Polypeptide transporter function in the human liver and whole-body - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Biomedicine and Pharmacotherapy Année : 2022

[$^{11}$C]glyburide PET imaging for quantitative determination of the importance of Organic Anion-Transporting Polypeptide transporter function in the human liver and whole-body

Résumé

Organic Anion-Transporting Polypeptides (OATPs) are known to control the liver uptake of many drugs. Non-hepatic expression of OATPs has been reported although functional importance for whole-body pharmacokinetics (WBPK) remains unknown. Glyburide is a well described substrate of several hepatic and non-hepatic OATPs. Dynamic whole-body positron emission tomography (DWB-PET) with [11C]glyburide was performed in humans for determination of the importance of OATPs for liver uptake and WBPK. Seven healthy male subjects (24.7 ± 3.2 years) underwent [$^{11}$]glyburide PET scan with concomitant blood sampling. All subjects underwent baseline [$^{11}$]glyburide PET scan. Five subjects underwent a subsequent [11C]glyburide PET scan after infusion of the potent OATP inhibitor rifampicin (9 mg/kg i.v.). The transfer constant ($k_{uptake}$) of [$^{11}$]glyburide from blood to the liver was estimated using the integration plot method. The tissue exposure of [11C]glyburide was described by the area under the time-activity curve (AUC) and corresponding tissue/blood ratio (AUCR). [$^{11}$]glyburide was barely metabolized in both the baseline and rifampicin conditions. Parent (unmetabolized) [$^{11}$]glyburide accounted for > 90 % of the plasma radioactivity. Excellent correlation was found between radioactive counting in arterial blood samples and in the image-derived input function, in both the baseline and rifampicin conditions (R$^2$ = 97.9 %, p < 0.01). [$^{11}$]glyburide predominantly accumulated in the liver. Rifampicin decreased liver $k_{uptake}$ by 77.3 ± 7.3 %, which increased exposure in blood, kidneys, spleen, myocardium and brain (p < 0.05). No significant change in AUCR was observed except in the liver (p < 0.01). [$^{11}$]glyburide benefits from metabolic stability and high sensitivity to OATP inhibition which enables quantitative determination of OATP function. DWB-PET suggests negligible role for non-hepatic OATPs in controlling the tissue distribution of [$^{11}$]glyburide.
Fichier principal
Vignette du fichier
1-s2.0-S075333222201383X-main.pdf (1.72 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03883032 , version 1 (02-12-2022)

Identifiants

Citer

Solène Marie, Louise Breuil, Zacharias Chalampalakis, Laurent Becquemont, Céline Verstuyft, et al.. [$^{11}$C]glyburide PET imaging for quantitative determination of the importance of Organic Anion-Transporting Polypeptide transporter function in the human liver and whole-body. Biomedicine and Pharmacotherapy, 2022, 156, pp.113994. ⟨10.1016/j.biopha.2022.113994⟩. ⟨hal-03883032⟩
31 Consultations
80 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More